Clough Global Opportunities Fund 的收入按细分市场或地理位置如何划分?
Calithera Biosciences Inc 最大收入来源是 Electronics,在最近的收益报告中收入为 1,526,236。就地区而言, United States 是 Calithera Biosciences Inc 的主要市场,收入为 2,856,133。
Clough Global Opportunities Fund 是否盈利?
否,根据最新的财务报表,Calithera Biosciences Inc 的净亏损为 $0
Clough Global Opportunities Fund 有负债吗?
否,Calithera Biosciences Inc 的负债为 0
Clough Global Opportunities Fund 的流通股有多少?
Calithera Biosciences Inc 的总流通股为 0
关键数据
前收盘价
$6.11
开盘价
$6.13
当日区间
$6.08 - $6.16
52周范围
$5.2 - $6.14
交易量
140.6K
平均成交量
159.9K
股息收益率
--
每股收益(TTM)
--
市值
$262.6M
什么是 GLO?
Clough Global Opportunities Fund is a US-based company operating in industry. The company is headquartered in Denver, Colorado. The company went IPO on 2006-04-26. Clough Global Opportunities Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to provide a high level of total return. The Fund seeks to pursue this objective by applying a fundamental research driven investment process and investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed income securities, including both corporate and sovereign debt, in both United States and non-United States markets. Under normal circumstances, the Fund expects to invest in securities of issuers located in at least three countries (in addition to the United States). The Fund also may invest in call options, both on specific equity securities, as well as securities representing exposure to equity sectors or indices and fixed income indices, including options on indices and ETFs. Its investment advisor is Clough Capital Partners L.P.